Star Lake Bioscience (600866.SH): Tie Xiaorong has reduced his shareholding by a total of 33.6938 million shares.

On May 7th, Gelonghui reported that Star Lake Bioscience (600866.SH) announced that on May 7, 2025, the company received a "Simplified Report on Equity Change" from its shareholder Tie Xiaorong and his concert party, Yipin Group, who hold more than 5% of the shares. Between April 22, 2025, and May 6, 2025, Tie Xiaorong reduced his shareholding by a total of 33.6938 million shares through block trading and centralized bidding, bringing his shareholding ratio down to 15.00%.

Gelonghui FinanceMay 7 19:37

Express News | Star Lake Bioscience conducted a block Trade today at a discount, with a transaction of 6.6599 million shares and a total amount of 50.9482 million yuan.

BreakingsMay 6 17:37

Star Lake Bioscience (600866.SH): Currently, the USA's tariff policy towards China will not have a significant impact on the company's production operation.

Gelonghui April 30th丨Star Lake Bioscience (600866.SH) stated on the interactive platform that in the international market, the company's products are exported to over 50 countries and regions including Europe, Southeast Asia, South Korea, etc. Currently, the USA's tariff policy on China will not have a significant impact on the company's Operation. The company will closely monitor changes in the international economic environment and related policies, actively researching and formulating response measures.

Gelonghui FinanceApr 30 17:02

Star Lake Bioscience (600866): The net income after excluding non-recurring items increased by 57.07% year-on-year, and the progress of ongoing projects is smooth.

Introduction to the report: The company achieved a net income of 1.142 billion yuan in 2024 after deducting non-recurring items, with a year-on-year increase of 57.07%, mainly benefiting from a significant increase in product sales; the company expects the total cash dividend distribution to account for 66% of the net income attributable to shareholders.

GUOTAI HAITONG SECApr 30 00:00

Earnings Miss: Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Missed EPS By 5.9% And Analysts Are Revising Their Forecasts

Simply Wall StApr 24 06:19

Star Lake Bioscience (600866): Profit surge demonstrates strong momentum, small variety amino acids build a new performance support point.

Event. On April 22, 2025, the company released the annual report for 2024 and the quarterly report for the first quarter of 2025. In 2024, the company achieved a revenue of 17.334 billion yuan, a year-on-year decrease of 0.23%; it achieved a net profit attributable to the parent company.

Minsheng SecuritiesApr 22 19:46